Table 4.

Impact of Clinical Culture Surveillance Results on Antimicrobial Prescribing

Patient No.	Sample	Discontinued	Started	Summary
3	Day 1			No change
6	Day 1	Caspofungin, piperacillin-tazobactam, vancomycin	Trimethoprim-sulfamethoxazole
	Day 3			No change
8	Day 7			No change
	Day 10			No change
17	Day 1	Ceftriaxone	Cefazolin
22	Day 3			No change*

^*Confirmed methicillin-resistant Staphylococcus aureus obtained from mini–bronchoalveolar lavage obtained 1 day before start of study.